Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-03-29
2005-03-29
Brumback, Brenda (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S012200
Reexamination Certificate
active
06872698
ABSTRACT:
The present invention relates to methods for treatment of nerve cell death (degeneration) and neurodegenerative diseases. Methods of the invention include administering, an effective amount of GDF-1 alone or in combination with neurotrophin-3, to a patient in need of such treatment such as a person suffering from stroke or traumatic brain injury or a neurodegenerative disease.
REFERENCES:
patent: 5635372 (1997-06-01), Celeste et al.
patent: 5652118 (1997-07-01), Ozkaynak et al.
patent: 5767252 (1998-06-01), Worley et al.
patent: WO 9200382 (1992-01-01), None
Rudinger, InPeptide Hormones, Q. A. Parsons, ed. University Park Press, Baltimore, pp. 1-7, 1976.*
L. Farkas et al.,Neuroscience Letters, 236:120-122 (1997).
Ebendal Ted
Jarpe Michael
Marchionni Mark
Brumback Brenda
Edwards & Angell LLP
Gucker Stephen
Hsi Jeffrey D.
O'Day Christine C.
LandOfFree
Methods for treating neurological injuries and disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating neurological injuries and disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating neurological injuries and disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3381995